Офлоксацин Тева 200 мг

Country: Israel

Language: Russian

Source: Ministry of Health

Active ingredient:

OFLOXACIN 200 MG

Available from:

ABIC LTD.

ATC code:

J01MA01

Pharmaceutical form:

TABLETS

Administration route:

PER OS

Manufactured by:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

Therapeutic group:

OFLOXACIN

Therapeutic indications:

Bacterial infections due to ofloxacin-susceptible microorganisms, such as:- acute, chronic, or recurrent lower respiratory tract infections (bronchitis) pneumonia (not for the treatment of first choice in pnemonia caused by pneumococci). - Chronic and recurrent infections of the ear, nose, and throat. Ofloxacin is in general not indicated for the treatment of acute tonsillitis caused by betahaemolytic streptococci. - Infections of soft tissues and skin. - Infections of the bones and joints. - Abdominal infections including infections in the pelvis minor and bacterial enteritis. - Infections of the kidney, urinary tract, and genital organs, gonorrhoea.Prevention of infections due to ofloxacin-susceptible pathogens in patients with a significant reduction in resistance to infections (e.g. in neutropenic state).

Authorization date:

2011-02-01